Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$101.21 - $166.61 $91,696 - $150,948
-906 Reduced 20.05%
3,613 $429,000
Q1 2024

May 14, 2024

SELL
$85.37 - $115.44 $660,166 - $892,697
-7,733 Reduced 63.12%
4,519 $481,000
Q4 2023

Jan 24, 2024

SELL
$69.51 - $104.43 $349,009 - $524,343
-5,021 Reduced 29.07%
12,252 $1.22 Million
Q3 2023

Nov 09, 2023

SELL
$96.41 - $126.61 $894,009 - $1.17 Million
-9,273 Reduced 34.93%
17,273 $1.78 Million
Q2 2023

Aug 08, 2023

BUY
$118.5 - $160.53 $1.48 Million - $2 Million
12,487 Added 88.82%
26,546 $3.23 Million
Q1 2023

May 05, 2023

SELL
$135.66 - $197.02 $1.24 Million - $1.8 Million
-9,116 Reduced 39.34%
14,059 $2.16 Million
Q4 2022

Feb 08, 2023

BUY
$118.38 - $210.04 $1.88 Million - $3.34 Million
15,897 Added 218.43%
23,175 $4.16 Million
Q3 2022

Nov 08, 2022

SELL
$118.07 - $194.18 $1.77 Million - $2.91 Million
-15,009 Reduced 67.34%
7,278 $861,000
Q2 2022

Aug 12, 2022

BUY
$117.13 - $176.59 $2.06 Million - $3.1 Million
17,556 Added 371.08%
22,287 $3.18 Million
Q4 2021

Feb 07, 2022

SELL
$225.82 - $368.51 $1.82 Million - $2.96 Million
-8,042 Reduced 62.96%
4,731 $1.2 Million
Q3 2021

Nov 09, 2021

BUY
$221.9 - $484.47 $2.83 Million - $6.19 Million
12,773 New
12,773 $4.92 Million
Q2 2021

Aug 12, 2021

SELL
$129.91 - $234.98 $147,447 - $266,702
-1,135 Closed
0 $0
Q1 2021

May 07, 2021

SELL
$109.18 - $185.98 $12,774 - $21,759
-117 Reduced 9.35%
1,135 $149,000
Q4 2020

Feb 03, 2021

SELL
$65.74 - $169.86 $576,737 - $1.49 Million
-8,773 Reduced 87.51%
1,252 $131,000
Q3 2020

Nov 06, 2020

SELL
$54.34 - $94.85 $2.72 Million - $4.74 Million
-49,995 Reduced 83.3%
10,025 $709,000
Q2 2020

Jul 17, 2020

BUY
$29.67 - $80.0 $1.76 Million - $4.75 Million
59,320 Added 8474.29%
60,020 $3.85 Million
Q1 2020

May 04, 2020

BUY
$17.78 - $31.58 $12,446 - $22,106
700 New
700 $21,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Prime Capital Investment Advisors, LLC Portfolio

Follow Prime Capital Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prime Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prime Capital Investment Advisors, LLC with notifications on news.